Expedited Scheduling of Histology and Histopathology
In today’s drug development environment, many of our clients have critical projects with tight timelines that need to be met in order to advance their programs.  This is particularly vital in the pre-IND (Investigational New Drug) phase of a preclinical drug development program.  Often, expedited histology and histopathology are requested immediately preceding submission of the IND to a regulatory agency or prior to the initiation of a longer term repeat dose study that depends on the findings of the previous investigation.  

Preliminary Planning and Project Management
The decision of when and where to send a study for expedited histology and/or histopathology is frequently prompted by delays in the initial schedule.  This is the point at which the work should either be starting or nearly finished, and it highlights the importance of preliminary planning and project management of the client’s workload.  Often the client is tasked with completing a study on schedule, while at the same time dealing with competing studies that must also be completed to meet management expectations.

Upcoming Events

41st NSH Annual Symposium
Members of EPL’s histology staff will be attending the National Society for Histotechnology (NSH) 41st Annual Symposium/Convention

Event: 41st NSH Annual Symposium
Date: Aug 28-Sep 2, 2015

Gaylord National Resort and Convention Center - Washington, DC

STP Midwest Symposium
Dr. Paul Snyder, Manager of EPL Midwest, will be the first speaker from 8:30am – 9:20am and speaking on  “Current Topics in Innate and Adaptive Immunity.”
EPL Blog about STP

Event: Society of Toxicologic Pathology
Date: September 16, 2015
Lilly Research Laboratories – Building 98 - Indianapolis, IN

ESTP 13th European Congress
Dr. Gabrielle Willson will be presenting two posters titled, “Right Ventricular Cardiomyopathy in the Rat—Is There an Association with Gavage?” and “Epididymal Histiocytic Sarcomas Identified in B6C3F1 Mouse Carcinogenicity Studies Conducted by the National Toxicology Program.”

Event: ESTP: 13th European Congress of Toxicologic Pathology
Date: Sept 22-27, 2015
Guildford, Surrey, UK


Profiled Team

Jerry F. Hardisty, DVM, Diplomate ACVP, Fellow IATP
CEO / President / Senior Pathologist
Paul W. Snyder, DVM, PhD, Diplomate ACVP, Fellow IATP
Manager, EPL Midwest / Senior Pathologist 

Kerry Crabb, DVM, HTL(ASCP)
Assistant Manager, NC Laboratory Operations 

Gabrielle A. Willson, DVM, Dip RCPath, FRC Path, MRCVS
Senior Pathologist 

Vivian English, HT(ASCP)
Histology / Tissue Repository Supervisor

EPL Slideshare Posts

Recent Slideshare Posts

EPL Newsletters

Recent Issues

EPL Poster Presentations

Recent Posters

Contact Us  
Paul Sanders, MBA
Marketing and Business Development Coordinator
PH (919) 998-9407  Ext 614

Meet EPL in 2015

STP 2015 Annual Meeting
American College of Veterinary Pathologists (ACVP), American Society for Veterinary Clinical Pathology (ASVCP), and the Society of Toxicologic Pathology (STP) Joint Annual Meeting
October 17-21, 2015
Minneapolis Convention Center
Minneapolis, MN

SETAC North America 36th Annual Meeting
November 1-5, 2015
Salt Lake City, UT

ACT 36th Annual Meeting
November 8-11, 2015
Red Rock Resort
Summerlin, NV

EPL History
Founded in 1971, Experimental Pathology Laboratories, Inc. (EPL®) is a private, employee-owned U.S. company that is recognized internationally for its ability to meet the needs of the scientific community and the challenges of preclinical safety testing with high quality, on-time histopathology services. More


A select group of technicians has been trained in animal necropsy techniques to form specialized EPL Necropsy Teams. In recent years, the demand for this unique service has increased significantly as the benefits have become apparent to the industry.


Experimental Pathology Laboratories, Inc. focuses on providing expert and timely GLP histology services to the toxicology research community. Our two fully-equipped histology laboratories are modern in design and are located in Sterling, Virginia.


EPL offers high quality immunohistochemical staining services using standard protocols developed in-house or transferred from the client. As many studies submitted to EPL do not have a protocol available for the intended antigen, species, or tissue to be studied, we offer support in developing new protocols or optimizing existing immunohistochemistry protocols.
Copyright ©   |  EPL, Inc.   2015   | All rights reserved.

Our mailing address is:
EPL, Inc.
PO Box 169
Sterling, VA 20167
Contact Paul Sanders for RFP, RFI opportunities
Email Paul Sanders